THE NATHANIEL WHARTON FUND
Our Mission
The Nathaniel Wharton Fund serves a unique function in support of innovative biomedical research at the intersection of mind, brain, and behavior with physical illness. The Fund supports a broad variety of projects in basic research, clinical care, and teaching at the Columbia University Medical Center. All activities are directed at finding practical ways to incorporate mind-body issues into the practices of medicine.
The Fund also provides ongoing support for Columbia University Cardiovascular Psychophysiology Laboratory, a central facility for research in mind-body interactions. The Fund's small size permits the rapid support of innovative projects as new mind-body medical issues arise. Since 1997, approximately $1.9 million in Wharton Fund research support has resulted in more than $50 million of funding.
Our Researchers
Richard Sloan, PhD
Richard Sloan, PhD, is the Nathaniel Wharton Professor of Behavioral Medicine (in Psychiatry) at the Columbia University Irving Medical Center.
Catherine Monk, PhD
Catherine Monk, PhD, is a Professor in the Departments of Obstetrics & Gynecology and Psychiatry at the Columbia University Irving Medical Center and Research Scientist VI at the New York State Psychiatric Institute.
Martin Picard, PhD
Martin Picard, PhD is the Herbert Irving Associate Professor of Behavioral Medicine (in Psychiatry and Neurology) at the Columbia University Irving Medical Center
World Wide Reach:
Wharton Fund Researchers Present Scientific Findings Across the Globe
The Nathaniel Wharton Fund plays a unique role in support of innovative biomedical research on important health issues at the intersection of mind, brain, behavior and physical illness.
Our Board
Ralph Wharton, MD
Executive DirectorProfessor of Clinical Psychiatry
Senior Consultant to Liaison Psychiatry Service
Richard Sloan, PHD
Director
Lennard Wharton, MD
Chair Emeritus
Philip Wharton
Chair
Peter Shapiro, MD
Secretary
Marcia Stein
Director
Janet K. Rodgers
Director